Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001790340-25-000046
Filing Date
2025-03-24
Accepted
2025-03-24 16:05:25
Documents
2
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1742846716.html 3  
1 FORM 3 wk-form3_1742846716.xml 3 1689
2 EX-24.1 matushanskyform3poa.htm EX-24.1 8218
  Complete submission text file 0001790340-25-000046.txt   11340
Mailing Address C/O HOOKIPA PHARMA INC. 430 EAST 29TH STREET NEW YORK NY 10016
Business Address
Matushansky Igor (Reporting) CIK: 0001768208 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40675 | Film No.: 25764159

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)